Ravindra Sarode, MD
Blood Banking & Transfusion Medicine · Dallas, TXNPI 1265493688
Payments from drug & device makers
Across 156 payments — averaging $8525.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cerus Corporation$1.2M
- Siemens Medical Solutions USA, Inc.$89K
- Argenx US, Inc.$28K
- CSL Behring$18K
- Octapharma USA, Inc.$7K
- Sanofi$6K
- plus $17K from 16 others
Across 31 payments — averaging $2082.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Octapharma USA, Inc.$65K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cerus Corporation | 60 | $1,164,574 |
| Siemens Medical Solutions USA, Inc. | 10 | $88,776 |
| Argenx US, Inc. | 4 | $28,487 |
| CSL Behring | 4 | $17,847 |
| Octapharma USA, Inc. | 15 | $6,691 |
| Sanofi | 10 | $6,355 |
| Novo Nordisk | 4 | $5,380 |
| Merck | 8 | $5,260 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,500 |
| Abbott | 19 | $1,945 |
| Gilead | 3 | $388 |
| AstraZeneca(2 entities) | 3 | $324 |
| Novartis | 3 | $324 |
| Sanofi-aventis U.S. LLC | 3 | $315 |
| Fresenius Kabi USA, LLC | 2 | $228 |
| Baxter Healthcare | 1 | $132 |
| Werfen USA LLC | 1 | $129 |
| ADMA Biomanufacturing LLC | 1 | $126 |
| Therakos LLC | 1 | $126 |
| Diagnostica Stago, Inc | 1 | $85 |
| Roche Diagnostics Corporation | 1 | $28 |
| Cvrx, Inc. | 1 | $23 |
How this compares
Too few blood banking & transfusion medicine providers in Texasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other blood banking & transfusion medicine in Dallas
- Sean YatesDallas$162K
- Laurie SutorDallas$90K
- James BurnerDallas$778
- Christopher WebbDallas$400
- Susan RossmannHouston$2.1M
- Arthur BraceyHouston$346K
- Mary TownsendAmarillo$34K
- Hlaing TintHouston$430
- Christopher GonzalezTemple$292
- Frances BenoistBedford$166
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.